About CD166 antigen
CD166 antigen (ALCAM) is a protein
from Homo sapiens identified by UniProt accession
Q13740, 583 residues long.
MolForge cross-references it against 0 known binders and
329 disease associations.
Target properties
| Protein name | CD166 antigen |
| UniProt accession | Q13740 |
| Gene | ALCAM |
| Organism | Homo sapiens |
| Length | 583 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (329)
Diseases linked to this target (Open Targets).
- mathematical ability · score 0.41
- body height · score 0.35
- cortical surface area measurement · score 0.32
- body mass index · score 0.31
- neuroimaging measurement · score 0.29
- neurodegenerative disease · score 0.29
- intraocular pressure measurement · score 0.28
- self reported educational attainment · score 0.28
- brain measurement · score 0.28
- irritability measurement · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13740-F1 | alphafold | PREDICTED | 85.94 | — |
Amino-acid sequence (583 residues)
MESKGASSCR LLFCLLISAT VFRPGLGWYT VNSAYGDTII IPCRLDVPQN LMFGKWKYEK PDGSPVFIAF RSSTKKSVQY DDVPEYKDRL NLSENYTLSI SNARISDEKR FVCMLVTEDN VFEAPTIVKV FKQPSKPEIV SKALFLETEQ LKKLGDCISE DSYPDGNITW YRNGKVLHPL EGAVVIIFKK EMDPVTQLYT MTSTLEYKTT KADIQMPFTC SVTYYGPSGQ KTIHSEQAVF DIYYPTEQVT IQVLPPKNAI KEGDNITLKC LGNGNPPPEE FLFYLPGQPE GIRSSNTYTL TDVRRNATGD YKCSLIDKKS MIASTAITVH YLDLSLNPSG EVTRQIGDAL PVSCTISASR NATVVWMKDN IRLRSSPSFS SLHYQDAGNY VCETALQEVE GLKKRESLTL IVEGKPQIKM TKKTDPSGLS KTIICHVEGF PKPAIQWTIT GSGSVINQTE ESPYINGRYY SKIIISPEEN VTLTCTAENQ LERTVNSLNV SAISIPEHDE ADEISDENRE KVNDQAKLIV GIVVGLLLAA LVAGVVYWLY MKKSKTASKH VNKDLGNMEE NKKLEENNHK TEA
Explore CD166 antigen with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets